Get the Stockscreener App
44.18
0.85%
-0.38
After Hours:
44.18
Qiagen Nv stock is traded at $44.18, with a volume of 1.41M.
It is down -0.85% in the last 24 hours and up +1.21% over the past month.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
See More
Previous Close:
$44.56
Open:
$44.73
24h Volume:
1.41M
Relative Volume:
0.53
Market Cap:
$9.12B
Revenue:
$2.10B
Net Income/Loss:
$402.17M
P/E Ratio:
22.82
EPS:
1.9357
Net Cash Flow:
$403.87M
1W Performance:
+1.96%
1M Performance:
+1.21%
6M Performance:
+8.74%
1Y Performance:
+0.57%
1-Day Range:
$43.99
$44.80
1-Week Range:
$42.56
$45.21
52-Week Range:
$32.53
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
44.18 | 9.12B | 2.10B | 402.17M | 403.87M | 1.9357 |
TMO
Thermo Fisher Scientific Inc
|
675.00 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
224.49 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
412.56 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.79 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.37 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-13-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-22-26 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Jun-24-25 | Initiated | Barclays | Overweight |
| Apr-04-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-06-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-10-24 | Upgrade | Jefferies | Hold → Buy |
| Oct-17-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jun-27-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Dec-07-23 | Upgrade | Goldman | Neutral → Buy |
| Sep-12-23 | Initiated | Robert W. Baird | Outperform |
| May-23-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-18-22 | Upgrade | DZ Bank | Hold → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Oct-14-21 | Initiated | Redburn | Buy |
| Jul-14-21 | Downgrade | Kepler | Buy → Hold |
| Jun-03-21 | Initiated | Goldman | Neutral |
| Oct-06-20 | Resumed | BofA Securities | Buy |
| Sep-28-20 | Upgrade | Kepler | Hold → Buy |
| Aug-24-20 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Aug-17-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-14-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-14-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-04-20 | Downgrade | Berenberg | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Dec-26-19 | Resumed | BofA/Merrill | Underperform |
| Nov-15-19 | Initiated | Stifel | Hold |
| Nov-14-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-14-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Nov-14-19 | Upgrade | Kepler | Reduce → Hold |
| Oct-17-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-09-19 | Downgrade | Kepler | Hold → Reduce |
| Oct-08-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-08-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-08-19 | Downgrade | JP Morgan | Neutral → Underweight |
View All
Qiagen Nv Stock (QGEN) Latest News
Qiagen N.V. (NYSE:QGEN) Stock Has Consensus Target Price of $43.51 - MarketBeat
Qiagen N.V. (QGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Qiagen stock last at EUR 39.470, up 1.64 percent in Xetra trading - AD HOC NEWS
Warren Wise decodes Qiagen’s DNA - TradingView
Qiagen stock gains 1.94 percent with Q2 results above estimates - AD HOC NEWS
Qiagen launches QIAmini to automate small-batch sample preparation - BioSpectrum Asia
Qiagen N.V. $QGEN Holdings Raised by State Street Corp - MarketBeat
Qiagen stock gains 1.43 percent ahead of the open - AD HOC NEWS
Qiagen launches compact automated sample prep system - Investing.com
Qiagen launches compact automated sample prep system By Investing.com - Investing.com Nigeria
QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation - marketscreener.com
Qiagen launches compact QIAmini sample prep system for small labs - StreetInsider
Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now - Yahoo Finance
Qiagen N.V. : Deutsche Bank remains its Buy rating - marketscreener.com
QIAGEN (NYSE:QGEN) Eyes Breakout With Technical Rating 7 and Setup Rating 9 - ChartMill
Qiagen stock heads into the open after a 3.4 percent gain - AD HOC NEWS
Qiagen stock was last quoted at USD 44.78 after the close - AD HOC NEWS
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
QIAGEN N.V. (QIA) Notified of Millennium 2.99% Stake - TradingView
QIAGEN N.V. (QIA) AFM Posts Voting Rights Notice - TradingView
QIAGEN N.V. (QIA) Discloses Goldman Sachs 3.41% Voting Rights - TradingView
QIAGEN N.V. (QIA) Notes AFM Voting Rights Filing by Goldman Sachs - TradingView
QIAGEN N.V. (QIA) Notes AFM Voting Rights Notification - TradingView
QIAGEN N.V. (QIA) Reports AFM Notice of BlackRock Voting Rights - TradingView
QIAGEN N.V. (QIA) Notes AFM Filing on BlackRock Voting Rights - TradingView
Qiagen stock holds at USD 44.78 below its yearly high - AD HOC NEWS
Qiagen stock heads into the open after a 1.36 percent drop - ad-hoc-news.de
Qiagen stock was last quoted after the close - AD HOC NEWS
Qiagen stock gains 3.05 percent near its yearly range - AD HOC NEWS
Qiagen stock heads into the open after a flat close - AD HOC NEWS
A Look at Qiagen NV (QGEN) After 3.4% Gain -- GF Value $49.88 vs Price $44.78 - gurufocus.com
Qiagen stock ends the day unchanged at the close on the NYSE - AD HOC NEWS
Qiagen stock reacts to CEO change and modest analyst upside - AD HOC NEWS
QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board - marketscreener.com
Qiagen N.V. (QGEN) Stock Forecasts - Yahoo Finance
Qiagen N.V. (QGEN) Stock Report: A Healthcare Giant With A Potential Upside Of 6.78% - DirectorsTalk Interviews
Magnetic Bead Purification Kits Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook - GlobeNewswire Inc.
Qiagen N.V. (QGEN) Presents at Berenberg and Goldman Sachs 15th German Corporate Conference 2026Slideshow (NYSE:QGEN) 2026-09-21 - Seeking Alpha
Qiagen stock heads into the open after a 2.27% drop - AD HOC NEWS
Qiagen stock slips after earnings beat narrows upside - AD HOC NEWS
Qiagen stock gains institutional backing as BlackRock stake disclosed - AD HOC NEWS
Qiagen schedules shareholder vote on new CEO appointment By Investing.com - Investing.com Canada
Qiagen schedules shareholder vote on new CEO appointment - Investing.com
QIAGEN N.V. (XETR:QIA) Receives AFM Notice of BlackRock Voting Rights Notification - TradingView
Qiagen stock gains on renewed takeover interest and CEO transition - AD HOC NEWS
QIAGEN N.V. (XETR:QIA) Discloses BlackRock Holding at 11.58% Capital, 12.99% Votes - TradingView
Qiagen stock heads into the open after a takeover-driven 4% jump - AD HOC NEWS
Qiagen NV (QGEN) Shares Surge 3.5% -- What GF Score of 75 Tells Investors - GuruFocus
BlackRock Emerges as Major Shareholder in Qiagen After AFM Disclosure - The Globe and Mail
Qiagen gains on report TPG, Bain Capital interested in takeover - Seeking Alpha
Qiagen Nv Stock (QGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):